ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Comparison of the Efficacy and Safety Profiles of a Pelubi Sustained Release Tab Versus a Pelubi Tab in Patients with Chronic Back Pain: A Randomized, Double-Blind, Multi-Institution Phase III Study
Journal of Korean Society of Spine Surgery
◽
10.4184/jkss.2016.23.2.92
◽
2016
◽
Vol 23
(2)
◽
pp. 84
Author(s):
Ki Taek Kim
◽
Tae Kyun Kim
◽
Ji Woong Choi
◽
Jae Sung Ahn
◽
Young Do Koh
◽
...
Keyword(s):
Back Pain
◽
Sustained Release
◽
Chronic Back Pain
◽
Phase Iii
◽
Efficacy And Safety
◽
Double Blind
◽
Phase Iii Study
Download Full-text
Related Documents
Cited By
References
Comparison of the Efficacy and Safety Profiles of a Pelubi Sustained Release Tab Versus a Pelubi Tab in Patients with Chronic Back Pain: A Randomized, Double-Blind, Multi-Institution Phase III Study
Journal of Korean Society of Spine Surgery
◽
10.4184/jkss.2016.23.2.84
◽
2016
◽
Vol 23
(2)
◽
pp. 84
Author(s):
Ki Taek Kim
◽
Tae Kyun Kim
◽
Ji Woong Choi
◽
Jae Sung Ahn
◽
Young Do Koh
◽
...
Keyword(s):
Back Pain
◽
Sustained Release
◽
Chronic Back Pain
◽
Phase Iii
◽
Efficacy And Safety
◽
Double Blind
◽
Phase Iii Study
Download Full-text
Efficacy and safety of oxymorphone extended release in chronic low back pain: Results of a randomized, double-blind, placebo- and active-controlled phase III study
Journal of Pain
◽
10.1016/j.jpain.2004.09.005
◽
2005
◽
Vol 6
(1)
◽
pp. 21-28
◽
Cited By ~ 110
Author(s):
Martin E. Hale
◽
Chris Dvergsten
◽
Joseph Gimbel
Keyword(s):
Low Back Pain
◽
Back Pain
◽
Chronic Low Back Pain
◽
Extended Release
◽
Phase Iii
◽
Low Back
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Phase Iii Study
Download Full-text
Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study
Expert Opinion on Pharmacotherapy
◽
10.1517/14656566.2010.497720
◽
2010
◽
Vol 11
(11)
◽
pp. 1787-1804
◽
Cited By ~ 162
Author(s):
Robert Buynak
◽
Douglas Y Shapiro
◽
Akiko Okamoto
◽
Ilse Van Hove
◽
Christine Rauschkolb
◽
...
Keyword(s):
Low Back Pain
◽
Back Pain
◽
Chronic Low Back Pain
◽
Extended Release
◽
Phase Iii
◽
Low Back
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Phase Iii Study
Download Full-text
Efficacy and safety of tapentadol ER for chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study
Journal of Pain
◽
10.1016/j.jpain.2009.01.321
◽
2009
◽
Vol 10
(4)
◽
pp. S50
◽
Cited By ~ 4
Author(s):
R. Buynak
◽
D. Shapiro
◽
A. Okamoto
◽
I. Van Hove
◽
M. Etropolski
Keyword(s):
Low Back Pain
◽
Back Pain
◽
Chronic Low Back Pain
◽
Phase Iii
◽
Low Back
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Phase Iii Study
Download Full-text
A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC
Case Medical Research
◽
10.31525/ct1-nct04033354
◽
2019
◽
Author(s):
Keyword(s):
Stage Iiib
◽
Phase Iii
◽
Line Treatment
◽
Efficacy And Safety
◽
First Line
◽
Double Blind
◽
Double Blind Placebo
◽
Phase Iii Study
◽
First Line Treatment
Download Full-text
A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Case Medical Research
◽
10.31525/ct1-nct04063163
◽
2019
◽
Author(s):
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Small Cell
◽
Phase Iii
◽
Efficacy And Safety
◽
Small Cell Lung
◽
Double Blind
◽
Double Blind Placebo
◽
Phase Iii Study
◽
Extensive Stage
Download Full-text
Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.718030851.793482493
◽
2013
◽
Author(s):
Joanne Jordan
◽
Amanda Nelson
Keyword(s):
Clinical Trial
◽
Sustained Release
◽
Hip Osteoarthritis
◽
Randomised Clinical Trial
◽
Phase Iii
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
◽
Multicentre Phase
◽
Parallel Group
Download Full-text
Faculty Opinions recommendation of Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718340215.793493941
◽
2014
◽
Author(s):
Kamran Ghoreschi
◽
Sebastian Volc
Keyword(s):
Monoclonal Antibody
◽
Plaque Psoriasis
◽
Phase Iii
◽
Efficacy And Safety
◽
Chronic Plaque Psoriasis
◽
Double Blind
◽
Phase Iii Study
Download Full-text
Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2014.01.897
◽
2014
◽
Vol 71
(3)
◽
pp. 484-492
◽
Cited By ~ 49
Author(s):
D.S. Krupashankar
◽
Sunil Dogra
◽
Mahendra Kura
◽
Abir Saraswat
◽
Leelavathy Budamakuntla
◽
...
Keyword(s):
Monoclonal Antibody
◽
Plaque Psoriasis
◽
Phase Iii
◽
Efficacy And Safety
◽
Chronic Plaque Psoriasis
◽
Double Blind
◽
Phase Iii Study
Download Full-text
Efficacy, safety, and gastrointestinal tolerability of tapentadol ER in a randomized, double-blind, placebo- and active-controlled phase III study of patients with chronic low back pain
Journal of Pain
◽
10.1016/j.jpain.2009.01.202
◽
2009
◽
Vol 10
(4)
◽
pp. S48
◽
Cited By ~ 5
Author(s):
R. Buynak
◽
D. Shapiro
◽
A. Okamoto
◽
C. Lange
◽
M. Etropolski
Keyword(s):
Low Back Pain
◽
Back Pain
◽
Chronic Low Back Pain
◽
Phase Iii
◽
Low Back
◽
Double Blind
◽
Double Blind Placebo
◽
Gastrointestinal Tolerability
◽
Phase Iii Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close